Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris

被引:27
|
作者
Batra, Gaurav [1 ]
Gurramkonda, Chandrasekhar [1 ]
Nemani, Satish Kumar [1 ]
Jain, Swatantra Kumar [2 ]
Swaminathan, Sathyamangalam [1 ]
Khanna, Navin [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, RGP Grp, New Delhi 110067, India
[2] Jamia Hamdard, Dept Biotechnol, New Delhi 110062, India
关键词
Dengue; Flavivirus; Envelope domain III; Pichia pastoris; Fed-batch cultivation; Vaccine; NEUTRALIZING ANTIBODIES; ESCHERICHIA-COLI; PROTEIN; EXPRESSION; GLYCOPROTEIN; INDUCTION; EPITOPES; ANTIGEN; VACCINE; BINDING;
D O I
10.1016/j.jbiosc.2010.05.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have developed a recombinant clone of the methylotrophic yeast Pichia pastoris capable of secreting dengue virus type 2 envelope domain III (sEDIII-2). We explored various induction parameters including media composition, temperature, pH, and methanol concentration, to optimize conditions for sEDIII-2 expression in shake flask culture. Induction at 20 degrees C in the presence of 2% (v/v) methanol in a medium buffered to pH 5.8 resulted in highest secretion of 5EDIII-2. This yield could be further enhanced up to 70% by repeated induction of the same initial biomass. Using a fed-batch cultivation strategy, we observed that shake-flask yields can be scaled up similar to 8-fold in a bioreactor. We obtained similar to 94% purity with >70% recovery after purification. This study, which demonstrates for the first time the feasibility of secreting envelope domain III using the P. pastoris host, will be relevant to sub-unit approaches to dengue vaccine development. (C) 2010, The Society for Biotechnology, Japan. All rights reserved.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 50 条
  • [21] Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis
    Lin, Guan-Ling
    Chang, Hsin-Hou
    Lien, Te-Sheng
    Chen, Po-Kong
    Chan, Hao
    Su, Mei-Tzu
    Liao, Chi-Yuan
    Sun, Der-Shan
    VIRULENCE, 2017, 8 (08) : 1719 - 1731
  • [22] The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris
    Sugrue, RJ
    Cui, TA
    Xu, QR
    Fu, JL
    Chan, YC
    JOURNAL OF VIROLOGICAL METHODS, 1997, 69 (1-2) : 159 - 169
  • [23] Thioaptamers targeting dengue virus type-2 envelope protein domain III
    Gandham, Sai Hari A.
    Volk, David E.
    Lokesh, Ganesh L. R.
    Neerathilingam, Muniasamy
    Gorenstein, David G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) : 309 - 315
  • [24] Production and characterization of recombinant dengue virus type 4 envelope domain III protein
    Tripathi, Nagesh K.
    Babu, J. Pradeep
    Shrivastva, Ambuj
    Parida, Manmohan
    Jana, Asha A.
    Rao, Rv. Lakshmana
    JOURNAL OF BIOTECHNOLOGY, 2008, 134 (3-4) : 278 - 286
  • [25] Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
    Yang, Jie
    Zhang, Junlei
    Chen, Wei
    Hu, Zhen
    Zhu, Junmin
    Fang, Xin
    Yuan, Wenchang
    Li, Ming
    Hu, Xiaomei
    Tan, Yinling
    Hu, Fuquan
    Rao, Xiancai
    CANADIAN JOURNAL OF MICROBIOLOGY, 2012, 58 (04) : 369 - 380
  • [26] Computer-aided Affinity Enhancement of a Cross-reactive Antibody against Dengue Virus Envelope Domain III
    Jonniya, Nisha Amarnath
    Poddar, Sayan
    Mahapatra, Subhasmita
    Kar, Parimal
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2023, 81 (04) : 737 - 755
  • [27] Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation
    Shanmugam, Rajgokul K.
    Ramasamy, Viswanathan
    Shukla, Rahul
    Arora, Upasana
    Swaminathan, Sathyamangalam
    Khanna, Navin
    PATHOGENS AND DISEASE, 2019, 77 (03):
  • [28] Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli
    Tripathi, Nagesh K.
    Shrivastava, Ambuj
    Biswal, Karttik C.
    Rao, P. V. Lakshmana
    BIOTECHNOLOGY JOURNAL, 2011, 6 (05) : 604 - 608
  • [29] Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen
    Batra, Gaurav
    Talha, Sheikh Mohd.
    Nemani, Satish Kumar
    Dhar, Nisha
    Swaminathan, Sathyamangalam
    Khanna, Navin
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 74 (01) : 99 - 105
  • [30] Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
    Ankur Poddar
    Viswanathan Ramasamy
    Rahul Shukla
    Ravi Kant Rajpoot
    Upasana Arora
    Swatantra K. Jain
    Sathyamangalam Swaminathan
    Navin Khanna
    BMC Biotechnology, 16